FSP1 has also been identified as a transcriptional target of Nrf2, and acts as the key effector in Nrf2-mediated ferroptosis resistance and radioresistance in KEAP1 deficient lung cancer cells [109, 111]. Here, NFE2L2 is linked to lung carcinoma.